Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Syndax Pharmaceuticals, Inc.W EXP 02 10 202(SNDX) | 904,000 | 27,330,800 | +26,426,800 | $11.95M | $48.10M | 7.21% | +$36.15M |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 312,336 | 27,330,800 | +27,018,464 | $830.8K | $48.10M | 7.21% | +$47.27M |
| Apellis Pharmaceuticals Inc COM | 3,006,980 | 2,094,000 | -912,980 | $95.95M | $45.80M | 6.87% | -$50.16M |
| Dianthus Therapeutics, Inc.(DNTH) | 2,110,167 | 2,341,667 | +231,500 | $46.00M | $42.48M | 6.37% | -$3.52M |
| ArriVent BioPharma, Inc.(AVBP) | 2,059,387 | 2,059,387 | 0 | $54.86M | $38.08M | 5.71% | -$16.78M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 3,322,000 | +3,322,000 | $0 | $20.90M | 3.13% | +$20.90M |
| Centessa Pharmaceuticals PlcADS | 1,993,052 | 1,425,000 | -568,052 | $33.38M | $20.49M | 3.07% | -$12.89M |
| Gossamer Bio, Inc.ADS(GOSS) | 18,350,000 | 1,425,000 | -16,925,000 | $16.60M | $20.49M | 3.07% | +$3.89M |
| Gossamer Bio, Inc.(GOSS) | 18,350,000 | 18,350,000 | 0 | $16.60M | $20.18M | 3.03% | +$3.59M |
| Ocular Therapeutix, Inc.(OCUL) | 2,425,000 | 2,425,000 | 0 | $20.71M | $17.78M | 2.67% | -$2.93M |
| Mind Medicine Mindmed Inc | 3,018,000 | 3,018,000 | 0 | $21.01M | $17.66M | 2.65% | -$3.35M |
| Cogent Biosciences, Inc.(COGT) | 2,763,000 | 2,763,000 | 0 | $21.55M | $16.55M | 2.48% | -$5.00M |
| Kalvista Pharmaceuticals Inc | 1,370,000 | 1,370,000 | 0 | $11.60M | $15.81M | 2.37% | +$4.21M |
| Taysha Gene Therapies, Inc.(TSHA) | 10,450,000 | 10,700,000 | +250,000 | $18.08M | $14.87M | 2.23% | -$3.21M |
| Taysha Gene Therapies Inc | 0 | 10,700,000 | +10,700,000 | $0 | $14.87M | 2.23% | +$14.87M |
| Scholar Rock Holding CorporationCL A(SRRK) | 488,000 | 7,900,000 | +7,412,000 | $21.09M | $13.90M | 2.08% | -$7.19M |
| Nuvation Bio Inc.CL A(NUVB) | 9,202,907 | 7,900,000 | -1,302,907 | $24.48M | $13.90M | 2.08% | -$10.58M |
| Humacyte, Inc.ADS(HUMA) | 0 | 217,264 | +217,264 | $0 | $13.79M | 2.07% | +$13.79M |
| Verona Pharma PlcADS | 571,264 | 217,264 | -354,000 | $26.53M | $13.79M | 2.07% | -$12.74M |
| Tourmaline Bio Inc | 0 | 905,000 | +905,000 | $0 | $13.77M | 2.06% | +$13.77M |
| Merus N V | 308,000 | 308,000 | 0 | $12.95M | $12.96M | 1.94% | +$12.3K |
| Pharvaris N V COM | 778,000 | 769,815 | -8,185 | $14.91M | $12.09M | 1.81% | -$2.83M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 296,000 | +296,000 | $0 | $11.56M | 1.73% | +$11.56M |
| Ocular Therapeutix, Inc.CL A(OCUL) | 2,425,000 | 296,000 | -2,129,000 | $20.71M | $11.56M | 1.73% | -$9.14M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 904,000 | 904,000 | 0 | $11.95M | $11.11M | 1.67% | -$845.2K |
| Atyr Pharma Inc | 900,000 | 3,552,000 | +2,652,000 | $3.26M | $10.73M | 1.61% | +$7.47M |
| Scholar Rock Holding Corp | 571,264 | 329,000 | -242,264 | $26.53M | $10.58M | 1.59% | -$15.95M |
| Scholar Rock Holding Corporation(SRRK) | 488,000 | 329,000 | -159,000 | $21.09M | $10.58M | 1.59% | -$10.51M |
| Verastem, Inc.(VSTM) | 0 | 1,720,000 | +1,720,000 | $0 | $10.37M | 1.56% | +$10.37M |
| ImmunityBio, Inc.(IBRX) | 0 | 1,720,000 | +1,720,000 | $0 | $10.37M | 1.56% | +$10.37M |
| Regulus Therapeutics Inc | 4,848,802 | 4,637,076 | -211,726 | $7.66M | $8.11M | 1.22% | +$453.8K |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 625,000 | +625,000 | $0 | $7.86M | 1.18% | +$7.86M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 1,230,000 | +1,230,000 | $0 | $7.69M | 1.15% | +$7.69M |
| Erasca, Inc.(ERAS) | 5,136,795 | 5,136,795 | 0 | $12.89M | $7.04M | 1.06% | -$5.86M |
| Viridian Therapeutics, Inc.(VRDN) | 870,000 | 450,000 | -420,000 | $16.68M | $6.07M | 0.91% | -$10.61M |
| Capricor Therapeutics, Inc.(CAPR) | 0 | 450,000 | +450,000 | $0 | $6.07M | 0.91% | +$6.07M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 1,115,000 | 1,115,000 | 0 | $13.16M | $5.92M | 0.89% | -$7.24M |
| Unicycive Therapeutics Inc | 10,000,000 | 10,000,000 | 0 | $7.94M | $5.75M | 0.86% | -$2.19M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 468,000 | +468,000 | $0 | $5.15M | 0.77% | +$5.15M |
| Nuvation Bio Inc.(NUVB) | 312,336 | 468,000 | +155,664 | $830.8K | $5.15M | 0.77% | +$4.32M |
| Perspective Therapeutics, Inc.(CATX) | 2,304,752 | 2,250,000 | -54,752 | $7.35M | $4.79M | 0.72% | -$2.56M |
| Kalaris Therapeutics, Inc.(KLRS) | 0 | 481,000 | +481,000 | $0 | $3.86M | 0.58% | +$3.86M |
| Nuvation Bio Inc.(NUVB) | 9,202,907 | 481,000 | -8,721,907 | $24.48M | $3.86M | 0.58% | -$20.62M |
| Neurogene Inc.(NGNE) | 303,000 | 303,000 | 0 | $6.93M | $3.55M | 0.53% | -$3.38M |
| Helix Acquisition Corp IiCL A | 250,000 | 250,000 | 0 | $2.63M | $2.83M | 0.42% | +$200.0K |
| Allovir Inc | 11,215,000 | 0 | -11,215,000 | $4.71M | $0 | — | -$4.71M |
| BridgeBio Pharma, Inc.(BBIO) | 441,600 | 0 | -441,600 | $12.12M | $0 | — | -$12.12M |
| Dyne Therapeutics, Inc.(DYN) | 668,000 | 0 | -668,000 | $15.74M | $0 | — | -$15.74M |
| Insmed Incorporated(INSM) | 332,000 | 0 | -332,000 | $22.92M | $0 | — | -$22.92M |
| Mersana Therapeutics Inc | 992,000 | 0 | -992,000 | $1.42M | $0 | — | -$1.42M |